CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 29 enrolled
Drug / intervention
Sentimarkdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02635737
NCT02635737N/ACompleted
CompareCT.gov

Safety and Feasibility Study of Magnetic Seed Markers to Localise Breast Cancers for Surgical Excision

Manchester University NHS Foundation Trust·interventional·Posted Dec 21, 2015·Updated Jan 15, 2021

In Brief

A clinical study evaluating Sentimark for Breast Cancer. Completed, enrolled 29 participants.

Detailed Summary

This is a single site, single arm, unblinded safety and feasibility cohort study investigating the use of magnetic marker seeds to localise breast tumours.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsBreast Cancer
Countries--
CollaboratorsEndomagnetics Inc

Timeline

N/ACompletedFinished
20162017201820192020202120222023202420252026
First PostedDec 21, 2015
Enrollment StartJul 6, 2016
Primary CompletionMay 3, 2017
TodayJul 2, 2026
Enrollment to primary: 10 monthsPosted 10.5 years ago

Interventions

Sentimarkdevice

Placement of a metallic clip with paramagnetic properties for tumour localisation